Slowing growth and lower margins are likely to put near-term pressure on Cognex Corporation CGNX, according to Goldman Sachs.
The Analyst
Joe Ritchie of Goldman Sachs downgraded Cognex from Buy to Neutral and lowered the stock’s 12-month price target from $78 to $55.
The Thesis
In the long run, Cognex will stand to benefit from technological adoption driven by automation tailwinds such as wage inflation, lack of skilled manufacturing workers and an aging factory installed base, Ritchie said in a Tuesday note.
“We continue to view CGNX as a high-quality franchise with best-in-class margins," he said.
This year could prove to be one of transition year for the machine vision company, as opex growth is likely to exceed topline growth, putting pressure on margins, Ritchie said.
“Opex is likely to grow faster than sales as CGNX continues to invest in longer-term secular opportunities."
Price Action
At the time of publication, Cognex shares were trading up 1.15 percent at $50.45.
Related Links:
5 Reasons Why Vuzix Is One Of Chardan Capital's Top Picks In 2018
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.